Fengjuan Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fengjuan Yao has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
Min Ye
Department of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China
8 shared publicationsJia Liu
Department of Cardiology the First Affiliated Hospital of Sun Yat‐Sen University Guangzhou Guangdong China
6 shared publicationsWei Li
Department of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
5 shared publicationsJing-Wei Zhang
Department of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
4 shared publicationsRui Fan
Department of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China
4 shared publicationsCui-Ling Li
Department of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China
3 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
Early postoperative prognostic markers of bioprosthetic mitral valve dysfunction in patients aged ≤ 70 years: a retrospective cohort study
Background: Although guidelines recommend bioprosthetic mitral valve replacement (MVRb) for patients aged 70 and older, an increasing number of younger patients (≤ 70 years) are undergoing MVRb due to specific clinical indications. This study aims to identify early postoperative prognostic markers associated with subsequent bioprosthetic mitral valve dysfunction (MVD) in patients ≤ 70 years who underwent MVRb. Methods: This retrospective study included 238 patients aged ≤ 70 years who underwent MVRb between January 2009 and December 2022. MVD was defined by new or progressive prosthetic morphological abnormalities with haemodynamic deterioration from the 1–3-month postoperative reference examination. LASSO-selected variables were entered into a multivariable cause-specific Cox model and incorporated into a nomogram. Internal validation used 1,000 selection-aware bootstrap resamples, and nomogram-based risk groups were compared using competing-risk analysis. Results: During a median echocardiographic follow-up of 166.2 months (IQR, 77.8–175.5 months), MVD occurred in 64 of 238 patients. NYHA functional class ≥ III (HR, 1.89; 95% CI, 1.13–3.17), PASP per 10 mmHg (HR, 1.93; 95% CI, 1.44–2.59), mean transmitral gradient per 1 mmHg (HR, 1.31; 95% CI, 1.16–1.49), and EOA per 0.5 cm² (HR, 0.51; 95% CI, 0.38–0.68) were independently associated with MVD (all P ≤ 0.05). Results were consistent in sensitivity analyses. The nomogram showed good internal discrimination, with an optimism-corrected C-index of 0.791 (95% CI, 0.740–0.840), with corrected AUCs of 0.842 and 0.809 at 7 and 10 years, respectively. Risk groups showed significantly different cumulative incidences of MVD (Gray’s P < 0.001). Conclusions: Key prognostic markers for MVD in younger patients who underwent MVRb include advanced NYHA class, elevated PASP, higher MG and reduced EOA. The nomogram may aid postoperative risk stratification, but external validation is required before clinical application.
- 10 November 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
Open AccessEarly postoperative prognostic markers of bioprosthetic mitral valve dysfunction in patients aged ≤ 70 years: a retrospective cohort study
Background: Although guidelines recommend bioprosthetic mitral valve replacement (MVRb) for patients aged 70 and older, an increasing number of younger patients (≤ 70 years) are undergoing MVRb due to specific clinical indications. This study aims to identify early postoperative prognostic markers associated with subsequent bioprosthetic mitral valve dysfunction (MVD) in patients ≤ 70 years who underwent MVRb. Methods: This retrospective study included 238 patients aged ≤ 70 years who underwent MVRb between January 2009 and December 2022. MVD was defined by new or progressive prosthetic morphological abnormalities with haemodynamic deterioration from the 1–3-month postoperative reference examination. LASSO-selected variables were entered into a multivariable cause-specific Cox model and incorporated into a nomogram. Internal validation used 1,000 selection-aware bootstrap resamples, and nomogram-based risk groups were compared using competing-risk analysis. Results: During a median echocardiographic follow-up of 166.2 months (IQR, 77.8–175.5 months), MVD occurred in 64 of 238 patients. NYHA functional class ≥ III (HR, 1.89; 95% CI, 1.13–3.17), PASP per 10 mmHg (HR, 1.93; 95% CI, 1.44–2.59), mean transmitral gradient per 1 mmHg (HR, 1.31; 95% CI, 1.16–1.49), and EOA per 0.5 cm² (HR, 0.51; 95% CI, 0.38–0.68) were independently associated with MVD (all P ≤ 0.05). Results were consistent in sensitivity analyses. The nomogram showed good internal discrimination, with an optimism-corrected C-index of 0.791 (95% CI, 0.740–0.840), with corrected AUCs of 0.842 and 0.809 at 7 and 10 years, respectively. Risk groups showed significantly different cumulative incidences of MVD (Gray’s P < 0.001). Conclusions: Key prognostic markers for MVD in younger patients who underwent MVRb include advanced NYHA class, elevated PASP, higher MG and reduced EOA. The nomogram may aid postoperative risk stratification, but external validation is required before clinical application.
- Open Access
- 22 October 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1911136
Brachial artery flow-mediated dilation and mean platelet volume in relation to diabetic retinopathy severity in type 2 diabetes: a retrospective cross-sectional study
Background: To evaluate the cross-sectional associations of brachial artery flow-mediated dilation (FMD) and mean platelet volume (MPV) with diabetic retinopathy (DR) severity in adults with type 2 diabetes mellitus (T2DM), after adjustment for age, sex, diabetes duration, glycated hemoglobin (HbA1c), and systolic blood pressure; carotid ultrasound measures were examined secondarily. Methods: This single-center, hospital-based cross-sectional study retrospectively analyzed clinical and imaging data obtained during routine inpatient care through a standardized multidisciplinary assessment pathway from 109 hospitalized adults with T2DM between June 2015 and December 2019: 46 with no DR (NDR), 36 with non-proliferative DR (NPDR), and 27 with proliferative DR (PDR). The main exploratory complete-case proportional-odds model included 86 participants (36 NDR, 30 NPDR, and 20 PDR) and simultaneously included age, sex, diabetes duration, HbA1c, systolic blood pressure, FMD, and MPV; a nephropathy-adjusted model and a ridge-penalized model were examined as sensitivity analyses. Results: Median FMD was 6.9%, 6.1%, and 5.3% in the NDR, NPDR, and PDR groups (Kruskal-Wallis P = .025), and median MPV was 9.30, 9.60, and 10.00 fL (P = .012). In the main exploratory complete-case model (N = 86), lower FMD (adjusted odds ratio [OR] per 1-percentage-point increase, 0.831; 95% CI, 0.713-0.968; P = .018) and higher MPV (adjusted OR per 1-fL increase, 1.898; 95% CI, 1.238-2.912; P = .003) were associated with greater DR severity. After additional adjustment for recorded diabetic nephropathy, the FMD estimate was attenuated (OR, 0.855; 95% CI, 0.732-0.998), whereas the MPV estimate was preserved (OR, 2.166; 95% CI, 1.356-3.458). In a ridge-penalized sensitivity model, both estimates were attenuated (FMD OR, 0.899 and 0.919; MPV OR, 1.388 and 1.289 at the minimum-loss and one-standard-error penalties, respectively). Conclusions: Lower brachial FMD and higher MPV were associated with greater DR severity in this selected hospital-based cross-sectional sample; the FMD association was sensitive to renal adjustment, and both associations, particularly that for MPV, were noticeably attenuated under penalization. These exploratory findings do not establish temporal sequence, causality, predictive performance, or clinical utility and require confirmation in larger prospective cohorts.
- 22 October 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1911136
Open AccessBrachial artery flow-mediated dilation and mean platelet volume in relation to diabetic retinopathy severity in type 2 diabetes: a retrospective cross-sectional study
Background: To evaluate the cross-sectional associations of brachial artery flow-mediated dilation (FMD) and mean platelet volume (MPV) with diabetic retinopathy (DR) severity in adults with type 2 diabetes mellitus (T2DM), after adjustment for age, sex, diabetes duration, glycated hemoglobin (HbA1c), and systolic blood pressure; carotid ultrasound measures were examined secondarily. Methods: This single-center, hospital-based cross-sectional study retrospectively analyzed clinical and imaging data obtained during routine inpatient care through a standardized multidisciplinary assessment pathway from 109 hospitalized adults with T2DM between June 2015 and December 2019: 46 with no DR (NDR), 36 with non-proliferative DR (NPDR), and 27 with proliferative DR (PDR). The main exploratory complete-case proportional-odds model included 86 participants (36 NDR, 30 NPDR, and 20 PDR) and simultaneously included age, sex, diabetes duration, HbA1c, systolic blood pressure, FMD, and MPV; a nephropathy-adjusted model and a ridge-penalized model were examined as sensitivity analyses. Results: Median FMD was 6.9%, 6.1%, and 5.3% in the NDR, NPDR, and PDR groups (Kruskal-Wallis P = .025), and median MPV was 9.30, 9.60, and 10.00 fL (P = .012). In the main exploratory complete-case model (N = 86), lower FMD (adjusted odds ratio [OR] per 1-percentage-point increase, 0.831; 95% CI, 0.713-0.968; P = .018) and higher MPV (adjusted OR per 1-fL increase, 1.898; 95% CI, 1.238-2.912; P = .003) were associated with greater DR severity. After additional adjustment for recorded diabetic nephropathy, the FMD estimate was attenuated (OR, 0.855; 95% CI, 0.732-0.998), whereas the MPV estimate was preserved (OR, 2.166; 95% CI, 1.356-3.458). In a ridge-penalized sensitivity model, both estimates were attenuated (FMD OR, 0.899 and 0.919; MPV OR, 1.388 and 1.289 at the minimum-loss and one-standard-error penalties, respectively). Conclusions: Lower brachial FMD and higher MPV were associated with greater DR severity in this selected hospital-based cross-sectional sample; the FMD association was sensitive to renal adjustment, and both associations, particularly that for MPV, were noticeably attenuated under penalization. These exploratory findings do not establish temporal sequence, causality, predictive performance, or clinical utility and require confirmation in larger prospective cohorts.
- Open Access
- 12 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (16) , 6230
Heterogeneity and Detection Rate of Hypertrophic Cardiomyopathy Phenotype in China: A Multicenter Echocardiography Study
Background: Contemporary data on the clinical detection rate and profile of phenotypical hypertrophic cardiomyopathy (HCM) in major Chinese healthcare settings are limited. This multicenter study aimed to determine the detection rate and echocardiographic features of the HCM phenotype in a large Chinese cohort. Methods: This cross-sectional study analyzed echocardiography databases from nine medical centers across China, including adult patients examined during 2023. HCM phenotype was defined as end-diastolic wall thickness ≥15 mm in the left ventricle. Patients with moderate to severe aortic stenosis were excluded. Subcategories included phenotypes of obstructive HCM and apical hypertrophy. Results: Among 655,383 examinations, 2610 patients met the criteria of the HCM phenotype, yielding a detection rate of 0.40% (≈1 in 250). The mean age was 60.2 years with male predominance (70.3%). Asymmetric septal hypertrophy was present in 53.3% of patients. The most commonly involved site with maximal wall thickness was the interventricular septum (57.6%), followed by the apex (20.9%) and the basal septum (17.7%). The overall intra-left ventricular obstruction rate was 16.2%; left ventricular outflow tract obstruction (LVOTO) accounted for 12.1%. LVOTO patients had greater septal thickness, smaller left ventricular diastolic dimensions, and more mitral regurgitation. Female sex was associated with a significantly higher LVOTO rate than males (18.2% vs. 9.6%, p < 0.001). Pure apical hypertrophy was identified in 4.5% of patients, with an increasing detection rate in older age groups. Conclusions: This large-scale, multicenter study confirms a high clinical detection rate for the HCM phenotype (≈1 in 250) in major Chinese centers. Substantial phenotypic heterogeneity across age and sex, coupled with the identification of key factors associated with LVOTO, highlights the need for sex- and age-specific diagnostic strategies and therapeutic planning in clinical practice.
- 12 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (16) , 6230
Open AccessHeterogeneity and Detection Rate of Hypertrophic Cardiomyopathy Phenotype in China: A Multicenter Echocardiography Study
Background: Contemporary data on the clinical detection rate and profile of phenotypical hypertrophic cardiomyopathy (HCM) in major Chinese healthcare settings are limited. This multicenter study aimed to determine the detection rate and echocardiographic features of the HCM phenotype in a large Chinese cohort. Methods: This cross-sectional study analyzed echocardiography databases from nine medical centers across China, including adult patients examined during 2023. HCM phenotype was defined as end-diastolic wall thickness ≥15 mm in the left ventricle. Patients with moderate to severe aortic stenosis were excluded. Subcategories included phenotypes of obstructive HCM and apical hypertrophy. Results: Among 655,383 examinations, 2610 patients met the criteria of the HCM phenotype, yielding a detection rate of 0.40% (≈1 in 250). The mean age was 60.2 years with male predominance (70.3%). Asymmetric septal hypertrophy was present in 53.3% of patients. The most commonly involved site with maximal wall thickness was the interventricular septum (57.6%), followed by the apex (20.9%) and the basal septum (17.7%). The overall intra-left ventricular obstruction rate was 16.2%; left ventricular outflow tract obstruction (LVOTO) accounted for 12.1%. LVOTO patients had greater septal thickness, smaller left ventricular diastolic dimensions, and more mitral regurgitation. Female sex was associated with a significantly higher LVOTO rate than males (18.2% vs. 9.6%, p < 0.001). Pure apical hypertrophy was identified in 4.5% of patients, with an increasing detection rate in older age groups. Conclusions: This large-scale, multicenter study confirms a high clinical detection rate for the HCM phenotype (≈1 in 250) in major Chinese centers. Substantial phenotypic heterogeneity across age and sex, coupled with the identification of key factors associated with LVOTO, highlights the need for sex- and age-specific diagnostic strategies and therapeutic planning in clinical practice.
- Open Access
- 18 June 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Primary left atrial spindle cell sarcoma with low-grade malignant features mimicking recurrent myxoma: a case report
Primary cardiac spindle cell sarcoma is extremely rare, with atypical clinical manifestations and imaging features. This case report details a 54-year-old female patient with a primary cardiac spindle cell sarcoma of the left atrium, initially thought to represent a recurrent cardiac myxoma. Despite utilizing multiple imaging techniques, the patient's complex clinical history complicated the diagnostic process, and the correct diagnosis was established after surgical resection and pathological evaluation. This case highlights the diagnostic pitfalls associated with presumed recurrent cardiac myxomas and underscores the importance of careful pathological assessment and long-term surveillance, even in tumors with low-grade malignant features.
- 18 June 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Open AccessPrimary left atrial spindle cell sarcoma with low-grade malignant features mimicking recurrent myxoma: a case report
Primary cardiac spindle cell sarcoma is extremely rare, with atypical clinical manifestations and imaging features. This case report details a 54-year-old female patient with a primary cardiac spindle cell sarcoma of the left atrium, initially thought to represent a recurrent cardiac myxoma. Despite utilizing multiple imaging techniques, the patient's complex clinical history complicated the diagnostic process, and the correct diagnosis was established after surgical resection and pathological evaluation. This case highlights the diagnostic pitfalls associated with presumed recurrent cardiac myxomas and underscores the importance of careful pathological assessment and long-term surveillance, even in tumors with low-grade malignant features.
- Open Access
- 1 June 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (6) , 509
Primary malignant cardiac tumor of the left atrium masqueraded as multiple myxomas
Primary malignant cardiac tumor of the left atrium masqueraded as multiple myxomas
- 1 June 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (6) , 509
Open AccessPrimary malignant cardiac tumor of the left atrium masqueraded as multiple myxomas
Primary malignant cardiac tumor of the left atrium masqueraded as multiple myxomas
- 29 May 2026
- Published by Springer Nature in Pituitary
- Vol. 29 (3)
Speckle-tracking echocardiography reveals the synergistic impact of GH/IGF-1 excess and metabolic dysregulation on cardiac dysfunction in acromegaly
Cardiac involvement in acromegaly is traditionally attributed to GH/IGF-1 excess, yet the subclinical impact of disease activity and metabolic comorbidities remains inadequately quantified. This study aims to characterize subclinical myocardial dysfunction in acromegaly using speckle-tracking echocardiography (STE) and explore its associations with disease activity, metabolic parameters, and treatment status. In this cross-sectional study, 74 patients with acromegaly (39 females) underwent detailed clinical, biochemical, and STE evaluation. STE-derived parameters of myocardial strain and work were analyzed including global longitudinal strain (GLS), left ventricular systolic dyssynchrony (LVSD), and global wasted work (GWW), and global work efficiency (GWE). Stratification by sex, treatment (naïve/active/remission), and metabolic profile was performed. Multivariable linear regressions identified predictors of cardiac structure/function. Male patients exhibited higher IGF-1 level, BMI, and more pronounced cardiac alterations than females (all p < 0.05). IGF-1 z-score was strongly correlated with cardiac structural indices (IVS thickness, r = 0.564; LVPW thickness, r = 0.431) and dysfunction (LVSD, r = 0.359; GWE, r = - 0.361; all p < 0.01). These associations were significantly potentiated in high-BMI and high-triglyceride-glucose (TyG) index subgroups. Patients achieving biochemical remission showed superior cardiac structure and function compared to untreated/active groups (p < 0.05). Multivariable linear regressions analysis identified IGF-1 z-score as an independent predictor of both LVPW thickness (β = 0.210, p = 0.045) and LVSD index (β = 2.249, p = 0.048), with BMI and male sex as additional predictors of LVPW thickening. Subclinical cardiac dysfunction in acromegaly is driven by IGF-1, exacerbated by metabolic factors, and improved with remission. STE supports early risk stratification and integrated management.
- 29 May 2026
- Published by Springer Nature in Pituitary
- Vol. 29 (3)
Speckle-tracking echocardiography reveals the synergistic impact of GH/IGF-1 excess and metabolic dysregulation on cardiac dysfunction in acromegaly
Cardiac involvement in acromegaly is traditionally attributed to GH/IGF-1 excess, yet the subclinical impact of disease activity and metabolic comorbidities remains inadequately quantified. This study aims to characterize subclinical myocardial dysfunction in acromegaly using speckle-tracking echocardiography (STE) and explore its associations with disease activity, metabolic parameters, and treatment status. In this cross-sectional study, 74 patients with acromegaly (39 females) underwent detailed clinical, biochemical, and STE evaluation. STE-derived parameters of myocardial strain and work were analyzed including global longitudinal strain (GLS), left ventricular systolic dyssynchrony (LVSD), and global wasted work (GWW), and global work efficiency (GWE). Stratification by sex, treatment (naïve/active/remission), and metabolic profile was performed. Multivariable linear regressions identified predictors of cardiac structure/function. Male patients exhibited higher IGF-1 level, BMI, and more pronounced cardiac alterations than females (all p < 0.05). IGF-1 z-score was strongly correlated with cardiac structural indices (IVS thickness, r = 0.564; LVPW thickness, r = 0.431) and dysfunction (LVSD, r = 0.359; GWE, r = - 0.361; all p < 0.01). These associations were significantly potentiated in high-BMI and high-triglyceride-glucose (TyG) index subgroups. Patients achieving biochemical remission showed superior cardiac structure and function compared to untreated/active groups (p < 0.05). Multivariable linear regressions analysis identified IGF-1 z-score as an independent predictor of both LVPW thickness (β = 0.210, p = 0.045) and LVSD index (β = 2.249, p = 0.048), with BMI and male sex as additional predictors of LVPW thickening. Subclinical cardiac dysfunction in acromegaly is driven by IGF-1, exacerbated by metabolic factors, and improved with remission. STE supports early risk stratification and integrated management.
- Open Access
- 1 April 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (4) , 293
Prospective evaluation of speckle-tracking echocardiography for detecting functionally significant coronary artery disease: a quantitative flow ratio-based study
Background: Functionally significant coronary artery disease (CAD) leads to myocardial perfusion deficits and cardiac dysfunction. Quantitative flow ratio (QFR) allows accurate assessment of functional stenosis without the need for pressure wire or adenosine. Traditional transthoracic echocardiography (TTE) and speckle-tracking echocardiography (STE) are commonly used to evaluate myocardial structure and function. This study aimed to evaluate and compare the diagnostic value of TTE and STE in identifying functionally significant coronary stenosis. Methods: A total of 112 hospitalized patients with suspected CAD underwent QFR assessment. Patients were divided into two groups based on QFR (QFR ≤0.8 and >0.8). TTE and STE were performed within 24 hours prior to coronary angiography. Logistic regression and receiver operating characteristic (ROC) curve analyses were used to evaluate the diagnostic performance of echocardiographic parameters. Results: Compared to the QFR >0.8 group, patients in the QFR ≤0.8 group showed significantly higher interventricular septal thickness (IVS, P=0.007), posterior wall thickness (P=0.038), and left ventricular mass index (LVMI, P=0.006). Basal longitudinal strain (Basal LS) was significantly lower in the QFR ≤0.8 group (P=0.008). Multivariate logistic regression identified Basal LS as an independent predictor of functionally significant CAD [odds ratio (OR) =1.148, P=0.039]. ROC analysis revealed comparable diagnostic performance for Basal LS [area under the curve (AUC) =0.634, P=0.016], IVS (AUC =0.653, P=0.005), and LVMI (AUC =0.683, P=0.001), with no statistically significant difference among them (all P>0.05). Conclusions: Basal LS is independently associated with functionally significant CAD. However, its diagnostic efficacy is limited and comparable to structural parameters such as IVS and LVMI. Combining STE with other imaging modalities, such as myocardial contrast echocardiography, may improve diagnostic accuracy.
- 1 April 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (4) , 293
Open AccessProspective evaluation of speckle-tracking echocardiography for detecting functionally significant coronary artery disease: a quantitative flow ratio-based study
Background: Functionally significant coronary artery disease (CAD) leads to myocardial perfusion deficits and cardiac dysfunction. Quantitative flow ratio (QFR) allows accurate assessment of functional stenosis without the need for pressure wire or adenosine. Traditional transthoracic echocardiography (TTE) and speckle-tracking echocardiography (STE) are commonly used to evaluate myocardial structure and function. This study aimed to evaluate and compare the diagnostic value of TTE and STE in identifying functionally significant coronary stenosis. Methods: A total of 112 hospitalized patients with suspected CAD underwent QFR assessment. Patients were divided into two groups based on QFR (QFR ≤0.8 and >0.8). TTE and STE were performed within 24 hours prior to coronary angiography. Logistic regression and receiver operating characteristic (ROC) curve analyses were used to evaluate the diagnostic performance of echocardiographic parameters. Results: Compared to the QFR >0.8 group, patients in the QFR ≤0.8 group showed significantly higher interventricular septal thickness (IVS, P=0.007), posterior wall thickness (P=0.038), and left ventricular mass index (LVMI, P=0.006). Basal longitudinal strain (Basal LS) was significantly lower in the QFR ≤0.8 group (P=0.008). Multivariate logistic regression identified Basal LS as an independent predictor of functionally significant CAD [odds ratio (OR) =1.148, P=0.039]. ROC analysis revealed comparable diagnostic performance for Basal LS [area under the curve (AUC) =0.634, P=0.016], IVS (AUC =0.653, P=0.005), and LVMI (AUC =0.683, P=0.001), with no statistically significant difference among them (all P>0.05). Conclusions: Basal LS is independently associated with functionally significant CAD. However, its diagnostic efficacy is limited and comparable to structural parameters such as IVS and LVMI. Combining STE with other imaging modalities, such as myocardial contrast echocardiography, may improve diagnostic accuracy.
- Open Access
- 25 February 2026
- Published by Springer Nature in Cardio-Oncology
- Vol. 12 (1)
Nedaplatin induced QT prolongation with polymorphic ventricular tachyarrhythmia: clinical experience and review of literature
Nedaplatin (NDP), a cisplatin derivative, is widely employed in the treatment of solid tumours. Commonly reported adverse effects include hypersensitivity,
- 25 February 2026
- Published by Springer Nature in Cardio-Oncology
- Vol. 12 (1)
Open AccessNedaplatin induced QT prolongation with polymorphic ventricular tachyarrhythmia: clinical experience and review of literature
Nedaplatin (NDP), a cisplatin derivative, is widely employed in the treatment of solid tumours. Commonly reported adverse effects include hypersensitivity,
- Open Access
- 1 January 2026
- Published by Bioscientifica in Endocrine Connections
- Vol. 15 (1)
Diagnostic and prognostic value of myocardial work indices in evaluating cardiac function damage in active acromegaly patients
Objective: Strain imaging serves as a sensitive marker for detecting early subclinical myocardial systolic dysfunction. The purpose of this study was to evaluate the diagnostic and prognostic value of myocardial work indices in assessing subclinical myocardial systolic dysfunction in active acromegaly patients. Methods: 27 active acromegaly patients and 27 healthy controls matched for age, sex, height, weight, body mass index and body surface area were included in the study. Active acromegaly was diagnosed based on elevated serum insulin-like growth factor 1 (IGF-1) (>1× upper limit of normal) or insufficient GH suppression (nadir ≥0.4 ng/mL) during an OGTT. All participants underwent two-dimensional speckle-tracking echocardiography (2D-STE) for the assessment of cardiac function. STE extracted the corresponding strain parameters (such as global longitudinal strain (GLS), global circumferential strain and global radial strain) and work parameters (such as global work index, global constructive work, global wasted work (GWW) and global work efficiency (GWE)) by analyzing the motion (strain)–velocity (strain rate) of two or more local myocardial segments, combined with the left ventricular non-invasive pressure estimation technique. At the same time, correlation analysis was used to explore the factors affecting GWW and GWE in the acromegaly group. Results: In comparison with the control group, conventional echocardiography revealed that acromegaly patients did not exhibit a significant difference in left ventricular ejection fraction (60.3 ± 3.7 vs 59.1 ± 4.8, P = 0.312), a commonly used index to evaluate ventricular systolic function, STE showed that there was no significant difference in GLS (−18.3 ± 2.4 vs −17.4 ± 2.9, P = 0.514) between the control group and the acromegaly group. However, significant differences can be found in GWW (44.8 ± 31.1 vs 80.6 ± 75.6, P = 0.027) and GWE (97.0 ± 1.8 vs 95.0 ± 3.8, P = 0.020), and a significant correlation was observed between myocardial work parameters and 1.5 × ULN IGF-1. Conclusion: GWW and GWE are sensitive markers for identifying subclinical myocardial systolic dysfunction, suggesting their potential as early markers for detecting subclinical myocardial systolic dysfunction in active acromegaly patients.
- 1 January 2026
- Published by Bioscientifica in Endocrine Connections
- Vol. 15 (1)
Open AccessDiagnostic and prognostic value of myocardial work indices in evaluating cardiac function damage in active acromegaly patients
Objective: Strain imaging serves as a sensitive marker for detecting early subclinical myocardial systolic dysfunction. The purpose of this study was to evaluate the diagnostic and prognostic value of myocardial work indices in assessing subclinical myocardial systolic dysfunction in active acromegaly patients. Methods: 27 active acromegaly patients and 27 healthy controls matched for age, sex, height, weight, body mass index and body surface area were included in the study. Active acromegaly was diagnosed based on elevated serum insulin-like growth factor 1 (IGF-1) (>1× upper limit of normal) or insufficient GH suppression (nadir ≥0.4 ng/mL) during an OGTT. All participants underwent two-dimensional speckle-tracking echocardiography (2D-STE) for the assessment of cardiac function. STE extracted the corresponding strain parameters (such as global longitudinal strain (GLS), global circumferential strain and global radial strain) and work parameters (such as global work index, global constructive work, global wasted work (GWW) and global work efficiency (GWE)) by analyzing the motion (strain)–velocity (strain rate) of two or more local myocardial segments, combined with the left ventricular non-invasive pressure estimation technique. At the same time, correlation analysis was used to explore the factors affecting GWW and GWE in the acromegaly group. Results: In comparison with the control group, conventional echocardiography revealed that acromegaly patients did not exhibit a significant difference in left ventricular ejection fraction (60.3 ± 3.7 vs 59.1 ± 4.8, P = 0.312), a commonly used index to evaluate ventricular systolic function, STE showed that there was no significant difference in GLS (−18.3 ± 2.4 vs −17.4 ± 2.9, P = 0.514) between the control group and the acromegaly group. However, significant differences can be found in GWW (44.8 ± 31.1 vs 80.6 ± 75.6, P = 0.027) and GWE (97.0 ± 1.8 vs 95.0 ± 3.8, P = 0.020), and a significant correlation was observed between myocardial work parameters and 1.5 × ULN IGF-1. Conclusion: GWW and GWE are sensitive markers for identifying subclinical myocardial systolic dysfunction, suggesting their potential as early markers for detecting subclinical myocardial systolic dysfunction in active acromegaly patients.
- Open Access
- 28 June 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (6)
Myocardial Blood Flow and the Retinal Microvasculature Across the Spectrum From Normal to Failing Hearts
Deficiency of the myocardial microcirculation plays a role in the pathogenesis of heart failure (HF). We aimed to investigate the association of myocardial blood flow (MBF) and the retinal microvasculature with left ventricular (LV) function and its potential mediators. In healthy controls (HCs; n = 48), patients with cardiovascular risk factors (CVRF; n = 49) and patients with compensated HF (CHF; n = 52), we assessed LV diastolic filling pressure (E/e′), LV ejection fraction (LVEF), and global longitudinal strain (GLS) associated with MBF and the retinal arteriole‐to‐venule ratio (AVR), using multivariable regression models, while considering their direct contributions to LV function and the indirect contributions running via NT‐proBNP. Compared with HC, CHF had lower MBF and smaller AVR (p ≤ 0.002). In all participants, smaller AVR was associated with higher E/e′, lower LVEF, and lower GLS (p ≤ 0.010). Per 1 dB × dB/s MBF reduction, E/e′ increased by 0.09, whereas LVEF and GLS decreased by 0.46% and 0.14%, respectively (p < 0.001). The indirect contributions running via NT‐proBNP were all significant (p < 0.001) for MBF and for AVR related to GLS (p = 0.044) with mediation proportions of ≥29%. Across subgroups, these associations were directionally similar but lost significance given the lower sample size. Furthermore, across the spectrum of LV function, estimates of the associations of MBF with E/e′ and AVR with GLS showed a decreasing versus increasing trend (p ≤ 0.034). MBF and retinal microvasculature were associated with LV function and counterbalance the impaired LV function in CHF. NT‐proBNP, the natural vasodilating and natriuretic hormone, contributes close to 30% of the maintenance of LV function.
- 28 June 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (6)
Open AccessMyocardial Blood Flow and the Retinal Microvasculature Across the Spectrum From Normal to Failing Hearts
Deficiency of the myocardial microcirculation plays a role in the pathogenesis of heart failure (HF). We aimed to investigate the association of myocardial blood flow (MBF) and the retinal microvasculature with left ventricular (LV) function and its potential mediators. In healthy controls (HCs; n = 48), patients with cardiovascular risk factors (CVRF; n = 49) and patients with compensated HF (CHF; n = 52), we assessed LV diastolic filling pressure (E/e′), LV ejection fraction (LVEF), and global longitudinal strain (GLS) associated with MBF and the retinal arteriole‐to‐venule ratio (AVR), using multivariable regression models, while considering their direct contributions to LV function and the indirect contributions running via NT‐proBNP. Compared with HC, CHF had lower MBF and smaller AVR (p ≤ 0.002). In all participants, smaller AVR was associated with higher E/e′, lower LVEF, and lower GLS (p ≤ 0.010). Per 1 dB × dB/s MBF reduction, E/e′ increased by 0.09, whereas LVEF and GLS decreased by 0.46% and 0.14%, respectively (p < 0.001). The indirect contributions running via NT‐proBNP were all significant (p < 0.001) for MBF and for AVR related to GLS (p = 0.044) with mediation proportions of ≥29%. Across subgroups, these associations were directionally similar but lost significance given the lower sample size. Furthermore, across the spectrum of LV function, estimates of the associations of MBF with E/e′ and AVR with GLS showed a decreasing versus increasing trend (p ≤ 0.034). MBF and retinal microvasculature were associated with LV function and counterbalance the impaired LV function in CHF. NT‐proBNP, the natural vasodilating and natriuretic hormone, contributes close to 30% of the maintenance of LV function.